The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Caveolin-1 Maintains Activated Akt in Prostate CancerCells through Scaffolding Domain Binding Site Interactions with andInhibition of Serine/Threonine Protein Phosphatases PP1 andPP2A
Open accessAbstract
Previously it has been reported that caveolin-1 (cav-1) has antiapoptotic activities in prostate cancer cells and functions downstream of androgenic stimulation. In this study, we demonstrate that cav-1 overexpression significantly reduced thapsigargin (Tg)-stimulated apoptosis. Examination of the phosphatidylinositol 3-kinase (PI3-K)/Akt signaling cascade revealed higher activities of PDK1 and Akt but not PI3-K in cav-1-stimulated cells compared to control cells. We subsequently found that cav-1 interacts with and inhibits serine/threonine protein phosphatases PP1 and PP2A through scaffolding domain binding site interactions. Deletion of the cav-1 scaffolding domain significantly reduces phosphorylated Akt and cell viability compared with wild-type cav-1. Analysis of potential substrates for PP1 and PP2A revealed that cav-1-mediated inhibition of PP1 and PP2A leads to increased PDK1, Akt, and ERK1/2 activities. We demonstrate that increased Akt activities are largely responsible for cav-1-mediated cell survival using dominant-negative Akt mutants and specific inhibitors to MEK1/MEK and show that cav-1 increases the half-life of phosphorylated PDK1 and Akt after inhibition of PI3-K by LY294002. We further demonstrate that cav-1-stimulated Akt activities lead to increased phosphorylation of multiple Akt substrates, including GSK3, FKHR, and MDM2. In addition, overexpression of cav-1 significantly increases translocation of phosphorylated androgen receptor to nucleus. Our studies therefore reveal a novel mechanism of Akt activation in prostate cancer and potentially other malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ushio-Fukai, M., Hilenski, L., Santanam, N., Becker, P. L., Ma, Y., Griendling, K. K., & Alexander, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105901200 · Cited by 204
RetractedThe phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
Caveolins, Liquid-Ordered Domains, and Signal Transduction
Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., & Lisanti, M. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7289 · Cited by 1,006
AKT plays a central role in tumorigenesis
Testa, J. R., & Bellacosa, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211430998 · Cited by 944
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Identification of Peptide and Protein Ligands for the Caveolin-scaffolding Domain
Couet, J., Li, S., Okamoto, T., Ikezu, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6525 · Cited by 918
Protein phosphatase 1 – targeted in many directions
Cohen, P. T. W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.2.241 · Cited by 912
Regulation of protein kinase cascades by protein phosphatase 2A
Millward, T. A., Zolnierowicz, S., & Hemmings, B. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01375-4 · Cited by 793
Serine/threonine protein phosphatases
Wera, S., & Hemmings, B. A. (1995) · Biochemical Journal · doi:10.1042/bj3110017 · Cited by 635
Alessi, D. R., Barry Caudwell, F., Andjelkovic, M., Hemmings, B. A., & Cohen, P. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01370-1 · Cited by 628
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Stahl, M., Dijkers, P. F., Kops, G. J. P. L., Lens, S. M. A., Coffer, P. J., Burgering, B. M. T., & Medema, R. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5024 · Cited by 585
Nakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8969-8982.2000 · Cited by 570
Wen, Y., Hu, M. C. ‐., Makino, K., Spohn, B., Bartholomeusz, G. A., Yan, D., & Hung, M. (2000) · PubMed · Cited by 531
Role of plasmalemmal caveolae in signal transduction
Shaul, P. W., & Anderson, R. G. W. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.5.l843 · Cited by 465
Jenkins, R. B., Qian, J., Lieber, M. M., & Bostwick, D. G. (1997) · PubMed · Cited by 443
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., & Schnitzer, J. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201661 · Cited by 421
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401
Graff, J. R., Konicek, B. W., McNulty, A. M., Wang, Z., Houck, K., Allen, S., Paul, J. D., Hbaiu, A., Goode, R. G., Sandusky, G. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003145200 · Cited by 378
Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16374 · Cited by 369
Alterations of the PPP2R1B Gene in Human Lung and Colon Cancer
Wang, S. S., Esplin, E. D., Li, J. L., Huang, L., Gazdar, A., Minna, J., & Evans, G. A. (1998) · Science · doi:10.1126/science.282.5387.284 · Cited by 363
Androgen Receptor Phosphorylation
Gioeli, D., Ficarro, S. B., Kwiek, J. J., Aaronson, D., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 351
Parpal, S., Karlsson, M., Thorn, H., & Strålfors, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007454200 · Cited by 340
Elevated expression of caveolin is associated with prostate and breast cancer.
Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., et al. (1998) · PubMed · Cited by 331
Self-citationProtein phosphatase 2A: the Trojan Horse of cellular signaling
Sontag, E. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00123-6 · Cited by 330
Erhardt, P., Schremser, E. J., & Cooper, G. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5308 · Cited by 306
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.
Yang, G., Truong, L. D., Wheeler, T. M., & Thompson, T. C. (1999) · PubMed · Cited by 283
Self-citationLOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER
YANG, R. M., NAITOH, J., MURPHY, M., WANG, H.-J., PHILLIPSON, J., DEKERNION, J. B., LODA, M., & REITER, R. E. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63776-5 · Cited by 278
Murillo, H. (2001) · Endocrinology · doi:10.1210/en.142.11.4795 · Cited by 263
Galbiati, F., Volonte', D., Liu, J., Capozza, F., Frank, P. G., Zhu, L., Pestell, R. G., & Lisanti, M. P. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2229 · Cited by 259
Caveolin-1 Interacts with Androgen Receptor
Lu, M. L., Schneider, M. C., Zheng, Y., Zhang, X., & Richie, J. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006598200 · Cited by 239
Kato, K., Hida, Y., Miyamoto, M., Hashida, H., Shinohara, T., Itoh, T., Okushiba, S., Kondo, S., & Katoh, H. (2002) · Cancer · doi:10.1002/cncr.10329 · Cited by 236
Ho, C.-C., Huang, P.-H., Huang, H.-Y., Chen, Y.-H., Yang, P.-C., & Hsu, S.-M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64442-2 · Cited by 228
Calin, G. A., di Iasio, M. G., Caprini, E., Vorechovsky, I., Natali, P. G., Sozzi, G., Croce, C. M., Barbanti-Brodano, G., Russo, G., & Negrini, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203389 · Cited by 219
Tahir, S. A., Yang, G., Ebara, S., Timme, T. L., Satoh, T., Li, L., Goltsov, A. A., Ittmann, M., Morrisett, J. D., & Thompson, T. C. (2001) · PubMed · Cited by 215
Self-citationLi, L., Yang, G., Ebara, S., Satoh, T., Nasu, Y., Timme, T. L., Ren, C., Wang, J., Tahir, S. A., & Thompson, T. C. (2001) · PubMed · Cited by 188
Self-citationRole of serine/threonine protein phosphatase 2A in cancer
Schönthal, A. H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00561-4 · Cited by 186
Zundel, W., Swiersz, L. M., & Giaccia, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1507-1514.2000 · Cited by 184
Nasu, Y., Timme, T. L., Yang, G., Bangma, C. H., Li, L., Ren, C., Park, S. H., DeLeon, M., Wang, J., & Thompson, T. C. (1998) · Nature Medicine · doi:10.1038/2048 · Cited by 181
Self-citationIvaska, J., Nissinen, L., Immonen, N., Eriksson, J. E., Kähäri, V.-M., & Heino, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1352-1359.2002 · Cited by 176
Ruediger, R., Pham, H. T., & Walter, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204059 · Cited by 171
Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.
Nestl, A., von Stein, O. D., Zatloukal, K., Thies, W. G., Herrlich, P. A., Hofmann‐Apitius, M., & Sleeman, J. P. (2001) · PubMed · Cited by 167
Caveolins and Cellular Cholesterol Balance
Ikonen, E., & Parton, R. G. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010303.x · Cited by 166
Caveolae and caveolin in immune cells: distribution and functions
Harris, J., Werling, D., Hope, J. C., Taylor, G., & Howard, C. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02161-5 · Cited by 156
Ruediger, R., Pham, H. T., & Walter, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204279 · Cited by 152
Recent Advances in Membrane Microdomains: Rafts, Caveolae, and Intracellular Cholesterol Trafficking
Schroeder, F., Gallegos, A. M., Atshaves, B. P., Storey, S. M., McIntosh, A. L., Petrescu, A. D., Huang, H., Starodub, O., Chao, H., Yang, H., et al. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122601002 · Cited by 147
Podar, K., Tai, Y., Cole, C. E., Hideshima, T., Sattler, M., Hamblin, A. D., Mitsiades, N., Schlossman, R. L., Davies, F. E., Morgan, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208636200 · Cited by 146
Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
Suzuoki, M., Miyamoto, M., Kato, K., Hiraoka, K., Oshikiri, T., Nakakubo, Y., Fukunaga, A., Shichinohe, T., Shinohara, T., Itoh, T., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600619 · Cited by 142
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation
Liu, J., Lee, P., Galbiati, F., Kitsis, R. N., & Lisanti, M. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c823 · Cited by 139
Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells.
Bonnefoy, N., Liu, Y., von Willebrand, M., Sung, A., Elly, C., Mustelin, T., Yoshida, H., Ishizaka, K., & Altman, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10142 · Cited by 138
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis
Timme, T. L., Goltsov, A. A., Tahir, S. A., Li, L., Wang, J., Ren, C., Johnston, R. N., & Thompson, T. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203654 · Cited by 129
Self-citationMousses, S., Wagner, U., Chen, Y., Kim, J. W., Bubendorf, L., Bittner, M. L., Pretlow, T. G., ELKAHLOUN, A. G., Trepel, J. B., & Kallioniemi, O. (2001) · Oncogene · doi:10.1038/sj.onc.1204889 · Cited by 123
Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.
Wu, D., Foreman, T. L., Gregory, C. W., et al. (2002) · PubMed · Cited by 121
Elevated Expression of Caveolin-1 in Adenocarcinoma of the Colon
Fine, S. W., Lisanti, M. P., Galbiati, F., & Li, M. (2001) · American Journal of Clinical Pathology · doi:10.1309/yl54-ccu7-4v0p-fdut · Cited by 118
Caveolin-I, a putative tumour suppressor gene
Razani, B., Schlegel, A., Liu, J., & Lisanti, M. P. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290494 · Cited by 116
Role of pRB dephosphorylation in cell cycle regulation
Tamrakar, S., Rubin, E., & Ludlow, J. W. (2000) · Frontiers in bioscience · doi:10.2741/tamrakar · Cited by 112
Caveolin-1 expression is associated with high-grade bladder cancer
Rajjayabun, P. H., Garg, S., Durkan, G. C., Charlton, R., Robinson, M., & Mellon, J. K. (2001) · Urology · doi:10.1016/s0090-4295(01)01337-1 · Cited by 111
Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang, R. M., Naitoh, J., Murphy, M., et al. (1998) · PubMed · Cited by 107
Gounari, F., Signoretti, S., Bronson, R. T., Klein, L., Sellers, W. R., Kum, J. B., Siermann, A., Taketo, M. M., von Boehmer, H., & Khazaie, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205562 · Cited by 104
Transition to androgen-independence in prostate cancer
Navarro, D., Luzardo, O. P., Fernández‐Pérez, L., Chesa, N., & Díaz-Chico, B. N. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00064-x · Cited by 94
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
Tahir, S. A., Ren, C., Timme, T. L., Gdor, Y., Hoogeveen, R. C., Morrisett, J. D., Frolov, A., Ayala, G., Wheeler, T. M., & Thompson, T. C. (2003) · PubMed · Cited by 86
Self-citationInvolvement of caveolae and caveolae-like domains in signalling, cell survival and angiogenesis
Massimino, M. L., Griffoni, C., Spisni, E., Toni, M., & Tomasi, V. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00232-7 · Cited by 77
Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid
Ito, Y., Yoshida, H., Nakano, K., Kobayashi, K., Yokozawa, T., Hirai, K., Matsuzuka, F., Matsuura∥, N., Kakudo, K., Kuma, K., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600172 · Cited by 67
mRTVP-1, a Novel p53 Target Gene with Proapoptotic Activities
Ren, C., Li, L., Goltsov, A. A., Timme, T. L., Tahir, S. A., Wang, J., Garza, L., Chinault, A. C., & Thompson, T. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3345-3357.2002 · Cited by 62
Self-citationCaveolin, cholesterol and Ras signalling
Sternberg, P. W., & Schmid, S. L. (1999) · Nature Cell Biology · doi:10.1038/10028 · Cited by 57
Caveolin-1 Expression in Advanced-Stage Ovarian Carcinoma— A Clinicopathologic Study
Davidson, B., Nesland, J. M., Goldberg, I., Kopolovic, J., Gotlieb, W. H., Bryne, M., Ben‐Baruch, G., Berner, A., & Reich, R. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6156 · Cited by 56
Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer
Thompson, T. C., Timme, T. L., Li, L., & Goltsov, A. A. (1999) · APOPTOSIS · doi:10.1023/a:1009612708099 · Cited by 52
Self-citationMapping and Gene Expression Profile of the Minimally Overrepresented 8q24 Region in Prostate Cancer
Tsuchiya, N., Kondo, Y., Takahashi, A., Pawar, H. S., Qian, J., Sato, K., Lieber, M. M., & Jenkins, R. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61126-1 · Cited by 41
Alterations of the PPP1R3 gene in human cancer.
Kohno, T., Takakura, S., Yamada, T., Okamoto, A., Tanaka, T., & Yokota, J. (1999) · PubMed · Cited by 33
Deichmann, M., Polychronidis, M., Wacker, J., Thome, M., & Näher, H. (2001) · Melanoma Research · doi:10.1097/00008390-200112000-00004 · Cited by 33
Cited by
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Karantanos, T., Corn, P. G., & Thompson, T. C. (2013) · Oncogene · doi:10.1038/onc.2013.206 · Cited by 866
Self-citationAdvances in protein kinase B signalling: AKTion on multiple fronts
Brazil, D. P., Yang, Z.-Z., & Hemmings, B. A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.006 · Cited by 830
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567
Metadata
- Authors
- Li, L., Ren, C. H., Tahir, S. A., Ren, C., & Thompson, T. C.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2003-12-01
- Volume
- 23
- Issue
- 24
- Pages
- 9389-9404
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2160269020
- Cited by
- 291
- References
- 78
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.